Methylene Blue Administration Reduces Acute Kidney Injury After Living Donor Liver Transplantation: A Single‐Center Retrospective Study
Artículo
Acceso abierto
Artículo
DOAJ
ABSTRACT Background and Aims The efficacy of methylene blue (MB) in preventing acute kidney injury (AKI) in liver transplant recipients remains unclear. In this study, we hypothesized that pre‐reperfusion administratio...
LCC LCC:MedicineIdioma eng
Acceso abiertoRuta libre sin proxy. Acceso recomendado cuando no hay suscripción activa.
Open Access